CHRNA7 and obesity disorder: Cholinergic drugs, including α7nAChR agonists and acetylcholinesterase (AChE) inhibitors, have also been shown to be cognitive enhancers and to reduce inflammation and metabolic imbalances in obesity and in MetS [22,23].